Literature DB >> 1277428

The protective effect of glucose-insulin-potassium on the response to atrial pacing.

M A Chiong, R West, J O Parker.   

Abstract

The effects of glucose-insulin-potassium infusion (GIK) on atrial pacing-induced angina, ST depression, abnormal left ventricular end-diastolic pressure during pacing interruption (LVEDPi) and lactate metabolism (L), were studied in 18 patients: ten had angina during pacing = Ischemic group, and eight (5 normals and 3 with coronary artery disease) remained asymptomatic = Nonischemic group. The study consisted of 8-10 minute periods of control, pacing and recovery, before and after GIK. No untoward effects were observed. Comparison of the pacing responses (GIK vs pre-GIK states) showed that during GIK, angina occurred in only 4 patients, while significantly less severe changes were observed in ST depression (1.4 +/-0.5 vs 2.4 +/- 0.4 mm) and LVEDPi (16 +/- 3 vs 23 +/- 3 mm Hg). Lactate extraction was also higher (8.1 +/- 10.9 vs -5.2 +/- 11.1%), but not significantly so, although L became normal in 4 subjects and improved in another. These results indicate that GIK infusion was well tolerated and had a beneficial effect on pacing-induced myocardial ischemia.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1277428     DOI: 10.1161/01.cir.54.1.37

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  3 in total

1.  Enhanced utilization of exogenous glucose improves cardiac function in hypoxic rabbit ventricle without increasing total glycolytic flux.

Authors:  E M Runnman; S T Lamp; J N Weiss
Journal:  J Clin Invest       Date:  1990-10       Impact factor: 14.808

2.  Effects of acute hyperglycemia on myocardial glycolytic activity in humans.

Authors:  J A Wisneski; W C Stanley; R A Neese; E W Gertz
Journal:  J Clin Invest       Date:  1990-05       Impact factor: 14.808

3.  Metabolic fate of extracted glucose in normal human myocardium.

Authors:  J A Wisneski; E W Gertz; R A Neese; L D Gruenke; D L Morris; J C Craig
Journal:  J Clin Invest       Date:  1985-11       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.